CT Cardiomegaly vs Lung Density Analysis

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Innolitics
VS
by 4DMedical

AI Verdict

Tool A, CT Cardiomegaly, is specifically designed for the automated measurement of cardiothoracic ratio from CT chest images to assist in cardiomegaly detection. In contrast, Tool B, Lung Density Analysis, focuses on quantitative analysis and 3D visualization of lung conditions like COPD and emphysema from CT scans. While both are AI-powered radiology tools utilizing CT data, their primary diagnostic targets and anatomical focus areas are distinct.

Choose CT Cardiomegaly if…

Choose CT Cardiomegaly if your primary need is automated, quantitative assessment of heart size relative to the thoracic cavity from CT chest images. This tool is ideal for rapidly obtaining precise linear and area-based cardiothoracic ratio measurements to aid in the detection and monitoring of cardiomegaly. Its command-line interface is suitable for integration into existing automated workflows.

View CT Cardiomegaly →

Choose Lung Density Analysis if…

Choose Lung Density Analysis if you require comprehensive quantitative analysis and 3D visualization of lung parenchyma, particularly for diagnosing and managing conditions such as COPD, emphysema, or air-trapping. This solution is well-suited for detailed assessment of lung density abnormalities, including mapping normal lung and air-trapping, and generating patient-centered reports for personalized lung care and smoking cessation counseling.

View Lung Density Analysis →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CT Cardiomegaly Lung Density Analysis
Pricing Fixed-fee Unknown
Deployment Docker Container (Ubuntu 20.04), command-line software Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Lung Density Analysis

Tool A is described as command-line software deployed via Docker, suggesting a more technical user experience. In contrast, Tool B offers multiple deployment options including cloud-based, PACS integration, and a stand-alone web-based interface, along with automated workflows, indicating a more user-friendly and accessible design for clinical environments.

Clinical Value

Lung Density Analysis

While Tool A provides quantitative cardiothoracic ratio measurements for cardiomegaly detection, Tool B offers a broader range of clinical insights. Tool B provides quantitative analysis and 3D visualization for various lung conditions like COPD and emphysema, including functional mapping and validation for low-dose CT scans, offering more comprehensive diagnostic and management support.

Pricing & Value

Tie

Both Tool A and Tool B state 'contact for pricing' and do not publicly disclose pricing details. Without specific pricing information or transparent value propositions, it is not possible to determine which tool offers better value.

Enterprise Readiness

Lung Density Analysis

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs. However, Tool B demonstrates greater enterprise readiness with its diverse deployment options, including cloud-based, locally virtualized, PACS integration, and AI marketplace availability. This flexibility allows for easier integration into various existing healthcare IT infrastructures compared to Tool A's command-line and Docker container deployment.

Innovation

Lung Density Analysis

Tool A focuses on automated cardiothoracic ratio measurement using machine learning for segmentation. Tool B, however, showcases more advanced innovative features such as 3D visualization, Imbio Noise Reduction Technology (NRT) for low-dose scans, and functional mapping of normal lung, air-trapping, and emphysema, which provide deeper and more nuanced analytical capabilities.

Support & Docs

Lung Density Analysis

IMBIO (Tool B) provides a dedicated support page with phone and email contacts, an online case submission form, defined support hours, and states that user manuals and product documentation are available upon request. Innolitics (Tool A) appears to be primarily a consultancy, offering general contact information but lacking specific, dedicated product support channels or readily available documentation for its CT Cardiomegaly tool.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CT Cardiomegaly Lung Density Analysis
Name CT Cardiomegaly Lung Density Analysis
Company Innolitics IMBIO
Description Innolitics' CT Cardiomegaly is an FDA-cleared AI-powered command-line software that automatically measures cardiothoracic ratio from CT chest images, assisting physicians in cardiomegaly detection with quantitative data. IMBIO's Lung Density Analysis is an AI-driven medical imaging software that provides quantitative analysis and 3D visualization of lung conditions from CT scans, aiding in the diagnosis and management of diseases like COPD and emphysema. It offers automated workflows and detailed reports for personalized patient care.
Tagline Automated Cardiothoracic Ratio Measurement from CT Images. AI-powered medical imaging analysis for personalized lung and cardiothoracic care.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Radiology & Imaging AI
Specialties Cardiology, Radiology Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring CT Cardiomegaly and Lung Density Analysis.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Innolitics' CT Cardiomegaly is designed to assist physicians in cardiomegaly detection by automatically measuring the cardiothoracic ratio from CT chest images, primarily supporting Cardiology and Radiology specialties. IMBIO's Lung Density Analysis focuses on providing quantitative analysis and 3D visualization of lung conditions from CT scans, aiding in the diagnosis and management of diseases like COPD, emphysema, asthma, and bronchiolitis obliterans, primarily for Pulmonology and Radiology.
CT Cardiomegaly calculates linear and area-based cardiothoracic ratios and outputs PDF and JSON reports. Lung Density Analysis provides automated detection, visualization, and quantification of emphysema, mapping of normal lung, air-trapping, and emphysema (Functional LDA), with quantitative reports that include coronal, axial, sagittal visuals, and bar charts.
Innolitics' CT Cardiomegaly is validated against manual measurements by board-certified radiologists. IMBIO's Lung Density Analysis is validated for low-dose CT scans in lung cancer screening.
Innolitics' CT Cardiomegaly is described as command-line software, suggesting a more manual integration or workflow. IMBIO's Lung Density Analysis explicitly mentions integration in PACS, AI marketplace/distribution platforms, and stand-alone web-based options.
CT Cardiomegaly utilizes non-adaptive machine learning algorithms using the MONAI framework for segmentation of the heart and thoracic cavity. Lung Density Analysis employs AI-driven medical imaging software with Imbio Noise Reduction Technology (NRT) to aid quantification and visualization of low-dose scans and advanced density analysis.
AI Tool Finder
AI-powered search. Results may not be comprehensive.